Spatial metabolite profiling identifies taurocholic acid as a protective mediator in hepatic ischemia-reperfusion injury: A mass spectrometry imaging and pharmacological study
Drug Metabolism and Disposition · 2026-08 · 54 (8) · 100357
DOI: 10.1016/j.dmd.2026.100357 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Metabolism and Disposition, 2026-08. Verfasst von Chuang Du und 8 weiteren Autor:innen. Beteiligte Einrichtung: Health Sciences Institute, China Medical University, Shenyang, Liaoning Province, P.R. China; Liaoning Key Laboratory of Obesity and Glucose/Lipid As…. Hauptthemen laut MEDLINE: Reperfusion Injury, Taurocholic Acid, Liver, Protective Agents. Die Arbeit nennt 41 Literaturangaben. Gefördert von: Shanghai University of Traditional Chinese Medicine, Liaoning Provincial Education Foundation, National Natural Science Foundation of China.
Abstract (Originalsprache)
Hepatic ischemia-reperfusion injury (IRI) remains a major clinical obstacle during liver surgery and liver transplantation, and effective targeted intervention strategies are still limited. In the present study, we combined mass spectrometry imaging, in vitro cellular experiments, and in vivo animal tests to explore key functional metabolites involved in the progression of hepatic IRI. Spatial metabolite profiling via mass spectrometry imaging systematically mapped metabolic disturbances in liver tissues during IRI progression and confirmed that taurocholic acid (TCA) undergoes distinct spatial and temporal expression alterations in damaged liver regions. Subsequent pharmacological experiments verified that exogenous TCA intervention effectively alleviated hepatic IRI damage. TCA exerted prominent hepatoprotective functions, including antiapoptosis, anti-inflammation, antioxidation, and promotion of bile acid excretion. Mechanistically, TCA activated hepatic farnesoid X receptor signaling, which further suppressed excessive inflammatory responses, restrained abnormal de novo bile acid synthesis, and facilitated bile acid efflux, thereby restoring hepatic bile acid homeostasis and relieving liver injury. SIGNIFICANCE STATEMENT: This study identifies taurocholic acid (TCA) as an important protective mediator against hepatic ischemia-reperfusion injury. Our results demonstrate that mass spectrometry imaging-based spatial metabolite analysis is a powerful approach to discover functional injury-related metabolites, whereas TCA-mediated farnesoid X receptor activation provides a feasible therapeutic strategy for the prevention and treatment of hepatic ischemia-reperfusion injury.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Health Sciences Institute, China Medical University, Shenyang, Liaoning Province, P.R. China; Liaoning Key Laboratory of Obesity and Glucose/Lipid Associated Metabolic Diseases, China Medical University, Shenyang, Liaon…
- Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai, P.R. China; Science and Technology Innovation Center, Shanghai Municipal Hospital of Tradition…
- Health Sciences Institute, China Medical University, Shenyang, Liaoning Province, P.R. China.
- Department of Gynecology Surgery 1, Cancer Hospital of China Medical University, Cancer Hospital of Dalian University of Technology, Liaoning Cancer Hospital & Institute, Shenyang, Liaoning, P.R. China.
- Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai, P.R. China. Electronic address: geguangbo@shutcm.edu.cn.
- Health Sciences Institute, China Medical University, Shenyang, Liaoning Province, P.R. China. Electronic address: wangzy@cmu.edu.cn.
Förderung
- Shanghai University of Traditional Chinese Medicine
- Liaoning Provincial Education Foundation
- National Natural Science Foundation of China
- Doctoral Scientific Research Start-up Project of Liaoning Provincial Natural Science Foundation
Zitieren
APA
Du, C., Xu, C. T., Zhang, Q., Chen, L., Zhao, S. S., Fan, Y. Z., Ge, G. B., Wang, Z. Y., & Liu, H. X. (2026). Spatial metabolite profiling identifies taurocholic acid as a protective mediator in hepatic ischemia-reperfusion injury: A mass spectrometry imaging and pharmacological study. Drug Metabolism and Disposition, 54(8), 100357. https://doi.org/10.1016/j.dmd.2026.100357
Vancouver
Du C, Xu CT, Zhang Q, Chen L, Zhao SS, Fan YZ, et al. Spatial metabolite profiling identifies taurocholic acid as a protective mediator in hepatic ischemia-reperfusion injury: A mass spectrometry imaging and pharmacological study. Drug Metabolism and Disposition. 2026;54(8):100357. doi:10.1016/j.dmd.2026.100357
BibTeX
@article{Du2026,
author = {Du, Chuang and Xu, Chu-Ting and Zhang, Qi and Chen, Lei and Zhao, Shan-Shan and Fan, Yi-Zhe and Ge, Guang-Bo and Wang, Zhan-You and Liu, Hui-Xin},
title = {Spatial metabolite profiling identifies taurocholic acid as a protective mediator in hepatic ischemia-reperfusion injury: A mass spectrometry imaging and pharmacological study},
journal = {Drug Metabolism and Disposition},
year = {2026},
volume = {54},
number = {8},
pages = {100357},
doi = {10.1016/j.dmd.2026.100357}
}
EUVIMED